Overexpression of human epidermal growth factor receptor 2 (HER2) is detected in 20 to 30% of invasive breast cancers (Vogel et al., 2002; Hudis, 2007; Beyer et al., 2011). Here, ERBB2 is linked to invasive breast carcinoma.